TFS
MBOT icon

Thoroughbred Financial Services’s Microbot Medical MBOT Stock Holding History

Thoroughbred Financial Services’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-27,000
Closed -$40K – 649
2025
Q1 		$40K Hold
27,000
– – ﹤0.01% 664
2024
Q4 		$30K Buy
27,000
+2,000
+8% +$1.96K ﹤0.01% 685
2024
Q3 		$22K Sell
25,000
-27,250
-52% -$26.6K ﹤0.01% 653
2024
Q2 		$53K Buy
+52,250
New +$53.7K ﹤0.01% 624

Other funds holding MBOT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Thoroughbred Financial Services's MBOT Position: Q2 2025 in Review

Thoroughbred Financial Services sold out of Microbot Medical (MBOT) in Q2 2025, closing a stake of 27,000 shares — an estimated $40K sold.

Thoroughbred Financial Services first reported a position in MBOT in Q2 2024 and held it in 4 quarters. The position peaked at $53K in Q2 2024. 49 funds tracked by Wall St. Rank hold MBOT as of Q2 2025.

  • Thoroughbred Financial Services reported no remaining Microbot Medical position as of Q2 2025 after selling out during the quarter.
  • Thoroughbred Financial Services sold 27,000 Microbot Medical shares in Q2 2025, an estimated $40K.
  • Thoroughbred Financial Services first reported a position in Microbot Medical in Q2 2024 and held it in 4 quarters.
  • Thoroughbred Financial Services's Microbot Medical position peaked at $53K in Q2 2024.
  • 49 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2025.

Based on Thoroughbred Financial Services's 13F filing for Q2 2025, filed 8 Aug 2025.